{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:44:48Z","timestamp":1784904288323,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271608"],"award-info":[{"award-number":["82271608"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiac fibrosis following myocardial infarction (MI) is a pivotal driver of ventricular dysfunction and heart failure, yet the molecular checkpoints orchestrating the persistent activation of cardiac fibroblasts remain incompletely defined. Here, we uncover a non-canonical, metabolism-independent function of Uridine-Cytidine Kinase 2 (UCK2) and Uridine-Cytidine Kinase Like-1 (UCKL1) as synergistic regulators of pathological remodeling. We demonstrate that both proteins are robustly upregulated in the border zone of ischemic murine hearts and transforming growth factor-\u03b2 (TGF-\u03b2)-activated human cardiac fibroblasts (HCFs). Mechanistically, UCK2 and UCKL1 physically assemble into an obligate functional complex that acts as a molecular scaffold rather than a metabolic enzyme. This complex recruits the E3 ubiquitin ligase Tripartite Motif Containing 21 (TRIM21) to orchestrate the specific ubiquitination and degradation of the negative regulator SMAD Specific E3 Ubiquitin Protein Ligase 2 (Smurf2), thereby sustaining SMAD Family Member 3 (Smad3) phosphorylation and amplifying fibrogenic TGF-\u03b2 signaling. Disruption of this axis via combined genetic silencing exerts a synergistic protective effect by abrogating myofibroblast differentiation and extracellular matrix production. Furthermore, therapeutic intervention using adeno-associated virus (AAV)-mediated knockdown of UCK2\/UCKL1 significantly attenuates adverse ventricular remodeling, limits scar expansion, and preserves cardiac function in a murine MI model. Collectively, these findings identify the UCK2\/UCKL1-TRIM21-Smurf2-Smad3 axis as a novel, druggable signalosome linking kinase \u201cmoonlighting\u201d functions to transcriptional reprogramming, offering a transformative therapeutic strategy to arrest the progression of post-ischemic heart failure.<\/jats:p>","DOI":"10.1186\/s43556-025-00397-x","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T03:43:38Z","timestamp":1766979818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Uridine-Cytidine Kinase 2 (UCK2)\/Uridine-Cytidine Kinase Like 1 (UCKL1) complex exacerbates the differentiation of myocardial fibroblasts via TRIM21\/Smurf2\/Smad3 pathway after myocardial infarction"],"prefix":"10.1186","volume":"6","author":[{"given":"Xiao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3145-2899","authenticated-orcid":false,"given":"Jun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"3","key":"397_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1161\/CIRCRESAHA.123.322596","volume":"133","author":"L Weng","year":"2023","unstructured":"Weng L, Ye J, Yang F, Jia S, Leng M, Jia B, et al. TGF-\u03b21\/SMAD3 regulates programmed cell death 5 that suppresses cardiac fibrosis post-myocardial infarction by inhibiting HDAC3. Circ Res. 2023;133(3):237\u201351. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.322596.","journal-title":"Circ Res"},{"key":"397_CR2","doi-asserted-by":"publisher","unstructured":"Amrute JM, Luo X, Penna V, Yang S, Yamawaki T, Hayat S, et al. Targeting immune\u2013fibroblast cell communication in heart failure. Nature. 2024:1-11. https:\/\/doi.org\/10.1038\/s41586-024-08008-5.","DOI":"10.1038\/s41586-024-08008-5"},{"issue":"11","key":"397_CR3","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.119.041882","volume":"141","author":"Y Hadas","year":"2020","unstructured":"Hadas Y, Vincek AS, Youssef E, \u017bak MM, Chepurko E, Sultana N, et al. Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction. Circulation. 2020;141(11):916\u201330. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041882.","journal-title":"Circulation"},{"key":"397_CR4","doi-asserted-by":"publisher","unstructured":"Cai S, Zhao M, Zhou B, Yoshii A, Bugg D, Villet O, et al. Mitochondrial dysfunction in macrophages promotes inflammation and suppresses repair after myocardial infarction. J Clin Invest. 2023;133(4). https:\/\/doi.org\/10.1172\/JCI159498.","DOI":"10.1172\/JCI159498"},{"issue":"4","key":"397_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s44161-022-00043-7","volume":"1","author":"SL Bowers","year":"2022","unstructured":"Bowers SL, Meng Q, Molkentin JD. Fibroblasts orchestrate cellular crosstalk in the heart through the ECM. Nat Cardiovasc Res. 2022;1(4):312\u201321. https:\/\/doi.org\/10.1038\/s44161-022-00043-7.","journal-title":"Nat Cardiovasc Res"},{"key":"397_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2020.05.006","volume":"91","author":"KY DeLeon-Pennell","year":"2020","unstructured":"DeLeon-Pennell KY, Barker TH, Lindsey ML. Fibroblasts: the arbiters of extracellular matrix remodeling. Matrix Biol. 2020;91:1\u20137. https:\/\/doi.org\/10.1016\/j.matbio.2020.05.006.","journal-title":"Matrix Biol"},{"issue":"3","key":"397_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cvr\/cvt338","volume":"101","author":"RB Driesen","year":"2014","unstructured":"Driesen RB, Nagaraju CK, Abi-Char J, Coenen T, Lijnen PJ, Fagard RH, et al. Reversible and irreversible differentiation of cardiac fibroblasts. Cardiovasc Res. 2014;101(3):411\u201322. https:\/\/doi.org\/10.1093\/cvr\/cvt338.","journal-title":"Cardiovasc Res"},{"key":"397_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105414","volume":"167","author":"R Singh","year":"2021","unstructured":"Singh R, Kaundal RK, Zhao B, Bouchareb R, Lebeche D. Resistin induces cardiac fibroblast-myofibroblast differentiation through JAK\/STAT3 and JNK\/c-Jun signaling. Pharmacol Res. 2021;167:105414. https:\/\/doi.org\/10.1016\/j.phrs.2020.105414.","journal-title":"Pharmacol Res"},{"issue":"9","key":"397_CR9","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.bbadis.2016.05.012","volume":"1862","author":"AB Van Kuilenburg","year":"2016","unstructured":"Van Kuilenburg AB, Meinsma R. The pivotal role of uridine-cytidine kinases in pyrimidine metabolism and activation of cytotoxic nucleoside analogues in neuroblastoma. BBA-Mol Basis Dis. 2016;1862(9):1504\u201312. https:\/\/doi.org\/10.1016\/j.bbadis.2016.05.012.","journal-title":"BBA-Mol Basis Dis"},{"issue":"5","key":"397_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.str.2004.02.038","volume":"12","author":"NN Suzuki","year":"2004","unstructured":"Suzuki NN, Koizumi K, Fukushima M, Matsuda A, Inagaki F. Structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase. Structure. 2004;12(5):751\u201364. https:\/\/doi.org\/10.1016\/j.str.2004.02.038.","journal-title":"Structure"},{"issue":"3","key":"397_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1107\/S0907444904032937","volume":"61","author":"TC Appleby","year":"2005","unstructured":"Appleby TC, Larson G, Cheney IW, Walker H, Wu JZ, Zhong W, et al. Structure of human uridine-cytidine kinase 2 determined by SIRAS using a rotating-anode X-ray generator and a single samarium derivative. Acta Crystallogr D Biol Crystallogr. 2005;61(3):278\u201384. https:\/\/doi.org\/10.1107\/S0907444904032937.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"397_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrep.2017.07.002","volume":"11","author":"F Tomoike","year":"2017","unstructured":"Tomoike F, Nakagawa N, Fukui K, Yano T, Kuramitsu S, Masui R. Indispensable residue for uridine binding in the uridine-cytidine kinase family. Biochem Biophys Rep. 2017;11:93\u20138. https:\/\/doi.org\/10.1016\/j.bbrep.2017.07.002.","journal-title":"Biochem Biophys Rep"},{"issue":"3","key":"397_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/leu.2013.330","volume":"28","author":"A Valencia","year":"2014","unstructured":"Valencia A, Masala E, Rossi A, Martino A, Sanna A, Buchi F, et al. Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. Leukemia. 2014;28(3):621\u20138. https:\/\/doi.org\/10.1038\/leu.2013.330.","journal-title":"Leukemia"},{"key":"397_CR14","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3389\/fonc.2020.00998","volume":"10","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Cheng Q, Xia M, Huang X, He X, Liao J. Hypoxia-induced lncRNA-NEAT1 sustains the growth of hepatocellular carcinoma via regulation of miR-199a-3p\/UCK2. Front Oncol. 2020;10:998. https:\/\/doi.org\/10.3389\/fonc.2020.00998.","journal-title":"Front Oncol"},{"issue":"1","key":"397_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41420-024-02140-x","volume":"10","author":"X Wu","year":"2024","unstructured":"Wu X, Chen D, Li M, Liang G, Ye H. UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K\/AKT\/mTOR\/autophagic axis. Cell Death Discov. 2024;10(1):375. https:\/\/doi.org\/10.1038\/s41420-024-02140-x.","journal-title":"Cell Death Discov"},{"key":"397_CR16","doi-asserted-by":"publisher","unstructured":"Wu H, Xu H, Jia D, Li T, Xia L. METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT\/\u03b2-catenin pathway. Ann Transl Med. 2021;9(14). https:\/\/doi.org\/10.21037\/atm-21-2906.","DOI":"10.21037\/atm-21-2906"},{"key":"397_CR17","doi-asserted-by":"publisher","unstructured":"Wu W, Zhao Y, Qin B, Jiang X, Wang C, Hu R, et al. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer. EBioMedicine. 2023;93. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104650.","DOI":"10.1016\/j.ebiom.2023.104650"},{"key":"397_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41389-020-00287-7","volume":"9","author":"J Cai","year":"2020","unstructured":"Cai J, Sun X, Guo H, Qu X, Huang H, Yu C, et al. Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma. Oncogenesis. 2020;9:103. https:\/\/doi.org\/10.1038\/s41389-020-00287-7.","journal-title":"Oncogenesis"},{"issue":"2","key":"397_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41418-021-00922-9","volume":"29","author":"JZ Roberts","year":"2022","unstructured":"Roberts JZ, Crawford N, Longley DB. The role of ubiquitination in apoptosis and necroptosis. Cell Death Differ. 2022;29(2):272\u201384. https:\/\/doi.org\/10.1038\/s41418-021-00922-9.","journal-title":"Cell Death Differ"},{"issue":"5","key":"397_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tcb.2023.09.001","volume":"34","author":"M Loix","year":"2024","unstructured":"Loix M, Zelcer N, Bogie JF, Hendriks JJ. The ubiquitous role of ubiquitination in lipid metabolism. Trends Cell Biol. 2024;34(5):416\u201329. https:\/\/doi.org\/10.1016\/j.tcb.2023.09.001.","journal-title":"Trends Cell Biol"},{"key":"397_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155378","volume":"139","author":"S Li","year":"2023","unstructured":"Li S, Lin Z, Xiao H, Xu Z, Li C, Zeng J, et al. Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis. Metabolism. 2023;139:155378. https:\/\/doi.org\/10.1016\/j.metabol.2022.155378.","journal-title":"Metabolism"},{"issue":"3","key":"397_CR22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.kint.2022.11.027","volume":"103","author":"Y Shi","year":"2023","unstructured":"Shi Y, Tao M, Chen H, Ma X, Wang Y, Hu Y, et al. Ubiquitin-specific protease 11 promotes partial epithelial-to-mesenchymal transition by deubiquitinating the epidermal growth factor receptor during kidney fibrosis. Kidney Int. 2023;103(3):544\u201364. https:\/\/doi.org\/10.1016\/j.kint.2022.11.027.","journal-title":"Kidney Int"},{"issue":"1","key":"397_CR23","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1038\/s41467-022-34971-6","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen H, Chew G, Devapragash N, Loh JZ, Huang KY, Guo J, et al. The E3 ubiquitin ligase WWP2 regulates pro-fibrogenic monocyte infiltration and activity in heart fibrosis. Nat Commun. 2022;13(1):7375. https:\/\/doi.org\/10.1038\/s41467-022-34971-6.","journal-title":"Nat Commun"},{"issue":"4","key":"397_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ni.2548","volume":"14","author":"WA McEwan","year":"2013","unstructured":"McEwan WA, Tam JC, Watkinson RE, Bidgood SR, Mallery DL, James LC. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat Immunol. 2013;14(4):327\u201336. https:\/\/doi.org\/10.1038\/ni.2548.","journal-title":"Nat Immunol"},{"issue":"1","key":"397_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","volume":"179","author":"HJ Kong","year":"2007","unstructured":"Kong HJ, Anderson DE, Lee CH, Jang MK, Tamura T, Tailor P, et al. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol. 2007;179(1):26\u201330. https:\/\/doi.org\/10.4049\/jimmunol.179.1.26.","journal-title":"J Immunol"},{"issue":"70","key":"397_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abj1640","volume":"7","author":"S Foss","year":"2022","unstructured":"Foss S, Jonsson A, Bottermann M, Watkinson R, Lode HE, McAdam MB, et al. Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge. Sci Immunol. 2022;7(70):eabj1640. https:\/\/doi.org\/10.1126\/sciimmunol.abj1640.","journal-title":"Sci Immunol"},{"key":"397_CR27","doi-asserted-by":"publisher","unstructured":"Wang Y-K, Ma N, Xu S, Huang J-Y, Ni Q-Z, Cao H-J, et al. PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1. Cell Rep. 2023;42(4). https:\/\/doi.org\/10.1016\/j.celrep.2023.112340.","DOI":"10.1016\/j.celrep.2023.112340"},{"issue":"1","key":"397_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add6626","volume":"9","author":"Z Fu","year":"2023","unstructured":"Fu Z, Chen S, Zhu Y, Zhang D, Xie P, Jiao Q, et al. Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity. Sci Adv. 2023;9(1):eadd6626. https:\/\/doi.org\/10.1126\/sciadv.add6626.","journal-title":"Sci Adv"},{"issue":"42","key":"397_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2406936121","volume":"121","author":"W-L Ye","year":"2024","unstructured":"Ye W-L, Huang L, Yang X-Q, Wan S, Gan W-J, Yang Y, et al. TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer. Proc Natl Acad Sci U S A. 2024;121(42):e2406936121. https:\/\/doi.org\/10.1073\/pnas.2406936121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"397_CR30","doi-asserted-by":"publisher","unstructured":"Lu X, Kong X, Wu H, Hao J, Li S, Gu Z, et al. UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders. Cell Metab. 2023;35(8):1390\u20131405. e1398. https:\/\/doi.org\/10.1016\/j.cmet.2023.05.011.","DOI":"10.1016\/j.cmet.2023.05.011"},{"key":"397_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114916","volume":"381","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Li Z, Peng Y, Li Z, Xv N, Jin L, et al. TRIM21-mediated ubiquitination of PLIN2 regulates neuronal lipid droplet accumulation after acute spinal cord injury. Exp Neurol. 2024;381:114916. https:\/\/doi.org\/10.1016\/j.expneurol.2024.114916.","journal-title":"Exp Neurol"},{"key":"397_CR32","doi-asserted-by":"publisher","unstructured":"Wen Y, Tian M, Jiang X, Gong Y, Gan H. Trim21 mediates metabolic reprogramming in renal tubular cells via PFKP ubiquitination to alleviate renal fibrosis. J Cell Physiol. e31439. https:\/\/doi.org\/10.1002\/jcp.31439.","DOI":"10.1002\/jcp.31439"},{"key":"397_CR33","doi-asserted-by":"publisher","unstructured":"Nikolaou KC, Godbersen S, Manoharan M, Wieland S, Heim MH, Stoffel M. Inflammation-induced TRIM21 represses hepatic steatosis by promoting the ubiquitination of lipogenic regulators. JCI insight. 2023;8(21). https:\/\/doi.org\/10.1172\/jci.insight.164694.","DOI":"10.1172\/jci.insight.164694"},{"issue":"23","key":"397_CR34","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1038\/emboj.2011.393","volume":"30","author":"LY Tang","year":"2011","unstructured":"Tang LY, Yamashita M, Coussens NP, Tang Y, Wang X, Li C, et al. Ablation of Smurf2 reveals an inhibition in TGF-\u03b2 signalling through multiple mono-ubiquitination of Smad3. EMBO J. 2011;30(23):4777\u201389. https:\/\/doi.org\/10.1038\/emboj.2011.393.","journal-title":"EMBO J"},{"issue":"10","key":"397_CR35","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1096\/fj.13-229187","volume":"27","author":"A Verga-G\u00e9rard","year":"2013","unstructured":"Verga-G\u00e9rard A, Porcherot M, Meyniel-Schicklin L, Andr\u00e9 P, Lotteau V, Perrin-Cocon L. Hepatitis C virus\/human interactome identifies SMURF2 and the viral protease as critical elements for the control of TGF-\u03b2 signaling. FASEB J. 2013;27(10):4027\u201340. https:\/\/doi.org\/10.1096\/fj.13-229187.","journal-title":"FASEB J"},{"issue":"1","key":"397_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00486-6","volume":"7","author":"X Lai","year":"2023","unstructured":"Lai X, Lui SKL, Lam HY, Adachi Y, Sim WJ, Vasilevski N, et al. SHP2 inhibitors maintain TGF\u03b2 signalling through SMURF2 inhibition. NPJ Precis Oncol. 2023;7(1):136. https:\/\/doi.org\/10.1038\/s41698-023-00486-6.","journal-title":"NPJ Precis Oncol"},{"key":"397_CR37","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.omtn.2020.12.003","volume":"23","author":"B Cai","year":"2021","unstructured":"Cai B, Li Z, Ma M, Zhang J, Kong S, Abdalla BA, et al. Long noncoding RNA SMUL suppresses SMURF2 production-mediated muscle atrophy via nonsense-mediated mRNA decay. Mol Ther Nucleic Acids. 2021;23:512\u201326. https:\/\/doi.org\/10.1016\/j.omtn.2020.12.003.","journal-title":"Mol Ther Nucleic Acids"},{"key":"397_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.849832","volume":"13","author":"J Zou","year":"2022","unstructured":"Zou J, Zhou X, Chen X, Ma Y, Yu R. Shenkang injection for treating renal fibrosis-metabonomics and regulation of E3 ubiquitin ligase smurfs on TGF-\u03b2\/Smads signal transduction. Front Pharmacol. 2022;13:849832. https:\/\/doi.org\/10.3389\/fphar.2022.849832.","journal-title":"Front Pharmacol"},{"key":"397_CR39","doi-asserted-by":"publisher","unstructured":"Huang Y, Border W, Kitagawa K, Hattori T, Suzuki S, Kitagawa M. Ubiquitin-dependent degradation of SnoN and ski is increased in renal fibrosis induced by obstructive injury. Kidney Int. 2006;69(10). https:\/\/doi.org\/10.1038\/sj.ki.5000261.","DOI":"10.1038\/sj.ki.5000261"},{"issue":"2","key":"397_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbamcr.2017.10.011","volume":"1865","author":"Y Cai","year":"2018","unstructured":"Cai Y, Huang G, Ma L, Dong L, Chen S, Shen X, et al. Smurf2, an E3 ubiquitin ligase, interacts with PDE4B and attenuates liver fibrosis through miR-132 mediated CTGF inhibition. BBA-Mol Cell Res. 2018;1865(2):297\u2013308. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.10.011.","journal-title":"BBA-Mol Cell Res"},{"issue":"1","key":"397_CR41","doi-asserted-by":"publisher","first-page":"14570","DOI":"10.1038\/ncomms14570","volume":"8","author":"Z Xu","year":"2017","unstructured":"Xu Z, Greenblatt MB, Yan G, Feng H, Sun J, Lotinun S, et al. SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts. Nat Commun. 2017;8(1):14570. https:\/\/doi.org\/10.1038\/ncomms14570.","journal-title":"Nat Commun"},{"issue":"3","key":"397_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1161\/CIRCRESAHA.122.320538","volume":"131","author":"C Ni","year":"2022","unstructured":"Ni C, Chen Y, Xu Y, Zhao J, Li Q, Xiao C, et al. FMO2 (flavin containing monooxygenase 2) prevents cardiac fibrosis via CYP2J3-SMURF2 axis. Circ Res. 2022;131(3):189\u2013206. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.320538.","journal-title":"Circ Res"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00397-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T03:43:38Z","timestamp":1766979818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00397-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00397-x","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were designed and strictly performed by our research team members of Renji Hospital. The animals were housed and maintained at the accredited facility of Youshu Life Technology Co., Ltd. All experimental procedures and protocols were conducted in strict accordance with the Guide for the Care and Use of Laboratory Animals and complied with the ethical standards and regulations of Renji Hospital, School of Medicine, Shanghai Jiao Tong University. The study protocols were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Youshu Life Technology Co., Ltd. (Approval No. YS-m202305003). Human tissue collection was approved by the Medical Ethics Committee of Renji Hospital, Shanghai Jiao Tong University School of Medicine (Approval No. KY2025-001-B). Written informed consent was obtained from all participants or their legal surrogates prior to inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}